PCK1 Regulates Glycolysis and Tumor Progression in Clear Cell Renal Cell Carcinoma Through LDHA

References

• Yoshida GJ. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res. 2015;34(1):111. doi:10.1186/s13046-015-0221-y26445347
   PubMed Web of Science ®Google Scholar
• Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119–1132. doi:10.1016/s0140-6736(09)60229-419269025
   PubMed Web of Science ®Google Scholar
• Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193–205. doi:10.1016/j.ctrv.2007.12.00118313224
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.116080919460998
   PubMed Web of Science ®Google Scholar
• Hanson RW, Garber AJ. Phosphoenolpyruvate carboxykinase. I. Its role in gluconeogenesis. Am J Clin Nutr. 1972;25(10):1010–1021. doi:10.1093/ajcn/25.10.10104342753
   PubMed Web of Science ®Google Scholar
• Nordlie RC, Lardy HA. Mammalian liver phosphoneolpyruvate carboxykinase activities. J Biol Chem. 1963;238:2259–2263.13938894
   PubMed Web of Science ®Google Scholar
• Chang HC, Maruyama H, Miller RS, Lane MD. The enzymatic carboxylation of phosphoenolpyruvate. 3. Investigation of the kinetics and mechanism of the mitochondrial phosphoenolpyruvate carboxykinase-catalyzed reaction. J Biol Chem. 1966;241(10):2421–2430.5911621
   PubMed Web of Science ®Google Scholar
• Vieira P, Cameron J, Rahikkala E, et al. Novel homozygous PCK1 mutation causing cytosolic phosphoenolpyruvate carboxykinase deficiency presenting as childhood hypoglycemia, an abnormal pattern of urine metabolites and liver dysfunction. Mol Genet Metab. 2017;120(4):337–341. doi:10.1016/j.ymgme.2017.02.00328216384
   PubMed Web of Science ®Google Scholar
• Valera A, Pujol A, Pelegrin M, Bosch F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994;91(19):9151–9154. doi:10.1073/pnas.91.19.91518090784
   PubMed Web of Science ®Google Scholar
• Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem. 2002;277(34):30409–30412. doi:10.1074/jbc.R20000620012087111
   PubMed Web of Science ®Google Scholar
• Montal ED, Dewi R, Bhalla K, et al. PEPCK coordinates the regulation of central carbon metabolism to promote cancer cell growth. Mol Cell. 2015;60(4):571–583. doi:10.1016/j.molcel.2015.09.02526481663
   PubMed Web of Science ®Google Scholar
• Ma R, Zhang W, Tang K, et al. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun. 2013;4(1):2508. doi:10.1038/ncomms350824149070
   PubMedGoogle Scholar
• Liu MX, Jin L, Sun SJ, et al. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene. 2018;37(12):1637–1653. doi:10.1038/s41388-017-0070-629335519
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang Y, Wang C, et al. Overexpression of PCK1 gene antagonizes hepatocellular carcinoma through the activation of gluconeogenesis and suppression of glycolysis pathways. Cell Physiol Biochem. 2018;47(1):344–355. doi:10.1159/00048981129768256
   PubMedGoogle Scholar
• Shi H, Fang R, Li Y, et al. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells. Cancer Lett. 2016;382(2):147–156. doi:10.1158/1078-0432.ccr-14-018627609066
   PubMed Web of Science ®Google Scholar
• Khan MW, Biswas D, Ghosh M, Mandloi S, Chakrabarti S, Chakrabarti P. mTORC2 controls cancer cell survival by modulating gluconeogenesis. Cell Death Discov. 2015;1(1):15016. doi:10.1038/cddiscovery.2015.1627551450
   PubMedGoogle Scholar
• Sanders E, Diehl S. Analysis and interpretation of transcriptomic data obtained from extended warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience. 2015;2(2):151–186. doi:10.18632/oncoscience.12825859558
   PubMedGoogle Scholar
• Sun X, Zhang H, Luo L, et al. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma. Oncol Rep. 2016;36(6):3131–3138. doi:10.3892/or.2016.515927748938
   PubMed Web of Science ®Google Scholar
• Dawson DM, Goodfriend TL, Kaplan NO, Kaplan NO. Lactic dehydrogenases: functions of the two types rates of synthesis of the two major forms can be correlated with metabolic differentiation. Science. 1964;143(3609):929–933. doi:10.1126/science.143.3609.92914090142
   PubMedGoogle Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.00626771115
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhao JS, Li JJ, et al. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics. 2010;9(12):2617–2628. doi:10.1074/mcp.M110.00066120699381
   PubMed Web of Science ®Google Scholar
• Girgis H, Masui O, White NM, et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer. 2014;13(1):101. doi:10.1186/1476-4598-13-10124885701
   PubMedGoogle Scholar
• Wang J, Wang H, Liu A, Fang C, Hao J, Wang Z. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget. 2015;6(23):19456–19468. doi:10.18632/oncotarget.331826062441
   PubMedGoogle Scholar
• Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer. 2003;89(5):877–885. doi:10.3109/09553002.2016.116292112942121
   PubMed Web of Science ®Google Scholar
• Huang X, Li X, Xie X, et al. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer. Breast. 2016;30:39–46. doi:10.1016/j.breast.2016.08.01427598996
   PubMed Web of Science ®Google Scholar
• He TL, Zhang YJ, Jiang H, Li XH, Zhu H, Zheng KL. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer. Med Oncol. 2015;32(7):187. doi:10.1007/s12032-015-0633-826021472
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Kakouratos C, Kalamida D, et al. Hypoxia-inducible proteins HIF1alpha and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer. Int J Radiat Biol. 2016;92(7):353–363. doi:10.1038/sj.bjc.660120527010533
   PubMed Web of Science ®Google Scholar
• Li L, Kang L, Zhao W, et al. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated warburg effect. Cancer Lett. 2017;400:89–98. doi:10.1016/j.canlet.2017.04.03428461244
   PubMed Web of Science ®Google Scholar
• Le A, Cooper CR, Gouw AM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A. 2010;107(5):2037–2042. doi:10.1073/pnas.091443310720133848
   PubMed Web of Science ®Google Scholar
• Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479–6483. doi:10.1158/1078-0432.CCR-09-088919861459
   PubMed Web of Science ®Google Scholar
• Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30(4):393–402. doi:10.1016/j.molcel.2008.04.00918498744
   PubMed Web of Science ®Google Scholar
• Cui J, Shi M, Xie D, et al. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res. 2014;20(10):2595–2606. doi:10.1158/1078-0432.CCR-13-240724634381
   PubMed Web of Science ®Google Scholar
• Shi M, Cui J, Du J, et al. A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Clin Cancer Res. 2014;20(16):4370–4380. doi:10.1158/1078-0432.ccr-14-018624947925
   PubMed Web of Science ®Google Scholar
• Zhao D, Zou SW, Liu Y, et al. Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell. 2013;23(4):464–476. doi:10.1016/j.ccr.2013.02.00523523103
   PubMed Web of Science ®Google Scholar
• Jeong H, Then F, Melia TJ Jr, et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell. 2009;137(1):60–72. doi:10.1016/j.cell.2009.03.01819345187
   PubMed Web of Science ®Google Scholar
• Cuervo AM. Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab. 2010;21(3):142–150. doi:10.1016/j.tem.2009.10.00319857975
   PubMed Web of Science ®Google Scholar
• Augoff K, Hryniewicz-Jankowska A, Tabola R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett. 2015;358(1):1–7. doi:10.1016/j.canlet.2014.12.03525528630
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.30913298683
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152. doi:10.1186/1476-4598-12-15224298908
   PubMed Web of Science ®Google Scholar
• Lu J, Tan M, Cai Q. The warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356(2Pt A):156–164. doi:10.1016/j.canlet.2014.04.00124732809
   PubMedGoogle Scholar
• Noda Y, Kanematsu M, Goshima S, et al. 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas. Eur Radiol. 2015;25(10):3009–3016. doi:10.1007/s00330-015-3687-225854217
   PubMed Web of Science ®Google Scholar
• Li Y, Luo S, Ma R, et al. Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors. Cancer Res. 2015;75(7):1191–1196. doi:10.1158/0008-5472.CAN-14-261525712344
   PubMed Web of Science ®Google Scholar
• Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys. 2007;48(2–3):89–95. doi:10.1007/s12013-007-0025-617709878
   PubMed Web of Science ®Google Scholar
• Li B, Qiu B, Lee DS, et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature. 2014;513(7517):251–255. doi:10.1038/nature1355725043030
   PubMed Web of Science ®Google Scholar
• Goldstein I, Yizhak K, Madar S, Goldfinger N, Ruppin E, Rotter V. p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab. 2013;1(1):9. doi:10.1186/2049-3002-1-924280180
   PubMedGoogle Scholar
• Smith B, Schafer XL, Ambeskovic A, Spencer CM, Land H, Munger J. Addiction to coupling of the warburg effect with glutamine catabolism in cancer cells. Cell Rep. 2016;17(3):821–836. doi:10.1016/j.celrep.2016.09.04527732857
   PubMed Web of Science ®Google Scholar
• Husain Z, Huang Y, Seth P, Sukhatme VP. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol. 2013;191(3):1486–1495. doi:10.4049/jimmunol.120270223817426
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen R, Xie W, Ni Y, Liu J, Huang G. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas. J Nucl Med. 2014;55(11):1766–1771. doi:10.2967/jnumed.114.14549025342384
   PubMed Web of Science ®Google Scholar
• Erez A, DeBerardinis RJ. Metabolic dysregulation in monogenic disorders and cancer - finding method in madness. Nat Rev Cancer. 2015;15(7):440–448. doi:10.1038/nrc394926084394
   PubMed Web of Science ®Google Scholar